Search for: "F.D.A."
Results 421 - 431
of 431
Sorted by Relevance
|
Sort by Date
2 Jul 2008, 8:08 pm
Evidence produced during a lawsuit against Bayer over the drug Baycol illustrates Bayer's apparently longstanding philosophy regarding drug side effects: A note written by a Bayer official read, ''If the F.D.A. asks for bad news, we have to give, but if we don't have it, then we can't give it to them. [read post]
1 Mar 2018, 1:10 pm
With respect to food regulations specifically, the federal Agency in charge of food handling is administered by the Australia Department of Health and Aging, and is Australia’s version of the F.D.A. [read post]
19 Dec 2013, 6:12 am
Contrary to popular belief – even among some lawyers – off-label use is not necessarily entirely off-label. [read post]
19 Nov 2007, 9:55 am
Today's (11.17.07) New York Times article by Joe Nocera "Forget Fair; It's Litigation As Usual," explores the world of mass tort litigation. [read post]
5 Jul 2013, 5:00 am
Thus, it is proper to instruct the jury that “F.D.A. action or inaction, though not dispositive, may be considered to show whether a product is safe or not safe. [read post]
8 Sep 2010, 12:07 am
With respect to food regulations specifically, the federal Agency in charge of food handling is administered by the Australia Department of Health and Aging, and is Australia’s version of the F.D.A. [read post]
6 Feb 2011, 1:59 am
Neuman last year also penned - "As Cheesemaking Blooms, So Can Listeria" and "Small Cheesemaker Defies F.D.A. [read post]
19 Sep 2013, 8:34 pm
Neuman last year also penned – “As Cheesemaking Blooms, So Can Listeria” and “Small Cheesemaker Defies F.D.A. [read post]
14 Mar 2017, 6:01 pm
Neuman last year also penned – “As Cheesemaking Blooms, So Can Listeria” and “Small Cheesemaker Defies F.D.A. [read post]
29 Jul 2016, 8:06 am
Neuman also penned – “As Cheesemaking Blooms, So Can Listeria” and “Small Cheesemaker Defies F.D.A. [read post]
19 Jul 2022, 2:59 pm
In the following guest post, the authors revisit the question of whether or not securities class action lawsuits against development-stage biotech companies are likelier to survive a motion to dismiss compared to securities suits against other kinds of companies. [read post]
